Quick Dispatch:
Your tirzepatide journal club Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM | Med Journal Club orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide journal club Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM | Med Journal Club ships.
Need Help?
Questions about tirzepatide journal club Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM | Med Journal Club, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide journal club Tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM | Med Journal Club in your area.
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
23.50
SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide
23.03
Tirzepatide Protocol Training as Medical Weight Loss Treatment
24.82
Journal Club on Cardiovascular Medicine: Key Insights & Emerging Evidence
23.28
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
26.84
A new ACP Journal Club is online now. Read about tailored precision immunotherapy for #sepsis, GLP-1 RAs for adults with #T1D and overweight or obesity, and more new evidence for #InternalMedicine from
21.21
CVOT of Tirzepatide vs Dulaglutide in Type 2 Diabetes: Journal club presentation
24.20
